Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Soft Mist Inhalers Market Growth Potential: How Will Market Size Shift Through 2030?
The soft mist inhalers market size has demonstrated substantial growth over recent years. It will grow from $3.06 billion in 2025 to $3.3 billion in 2026 at a compound annual growth rate (CAGR) of 8.0%. This historical growth can be linked to factors such as rising asthma prevalence, an increase in COPD cases, the limitations of traditional inhalers, the expansion of hospital-based respiratory care, and an aging population.
The soft mist inhalers market is projected for significant expansion over the coming years. It is anticipated to reach $4.48 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 7.9%. This projected growth during the forecast period is fueled by factors such as the expansion of home-based respiratory treatment, advancements in inhaler design, escalating pollution levels, a rise in chronic respiratory ailments, and the broader availability of outpatient care. Key developments anticipated in this period encompass the wider adoption of soft mist drug delivery technology, an increasing demand for inhalers that are easy for patients to use, greater application in the management of asthma and COPD, the proliferation of homecare respiratory devices, and an emphasis on enhancing drug deposition efficiency.
Get A Free Sample Report With In-Depth Market Insights:
Soft Mist Inhalers Market Growth Momentum: What Factors Are Shaping Demand?
The increasing occurrence of asthma is anticipated to drive the expansion of the soft mist inhalers market in the future. Asthma, a long-term respiratory ailment, leads to airway inflammation and constriction, resulting in breathing difficulties. This rise in asthma cases is largely attributed to greater exposure to air pollution, which worsens respiratory issues and progressively damages lung function. Soft mist inhalers aid in managing asthma and other chronic obstructive pulmonary conditions by directly delivering a gentle, slowly dispersing mist of medication to the lungs, thereby enhancing drug absorption and providing respiratory comfort with little effort. As an illustration, the National Asthma Council, an Australia-based non-profit organization, reported in October 2024 that Australia registered 474 asthma-related fatalities in 2023, consisting of 325 females and 149 males. This count is nearly identical to the 473 asthma-related deaths documented in 2022, indicating a steady pattern in asthma mortality across both years. Consequently, the growing prevalence of asthma is stimulating the expansion of the soft mist inhalers market.
Soft Mist Inhalers Market Segment Landscape And Growth Outlook
The soft mist inhalers market covered in this report is segmented –
1) By Product Type: Portable Soft Mist Inhalers, Stationary Soft Mist Inhalers
2) By Application: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory Diseases, Other Applications
3) By End-User: Hospitals And Clinics, Home Care Settings, Other End-Users
Subsegments:
1) By Portable Soft Mist Inhalers: Handheld Reusable Soft Mist Inhalers, Disposable Single-Use Soft Mist Inhalers, Compact Travel-Friendly Inhalers, Pediatric-Use Portable Soft Mist Inhalers
2) By Stationary Soft Mist Inhalers: Homecare-Use Stationary Inhalers, Hospital-Grade Soft Mist Inhalers, Long-Term Therapy Devices
Soft Mist Inhalers Market Trends Redefining Industry Growth
Leading entities within the soft mist inhalers (SMIs) sector are emphasizing collaborative strategies to broaden their market reach and improve product availability. These organizations seek to capitalize on mutual advantages and secure a competitive position in providing groundbreaking, patient-focused inhalation treatments through alliances with research bodies, technology enterprises, and local healthcare providers. A notable illustration occurred in 2024 when Merxin Ltd., a UK-based firm focused on designing and supplying generic and bespoke inhaler devices, joined forces with OECHSLERhealth, a Germany-based producer of medical devices, to introduce the Soft Mist Inhalers (SMI) Powerhouse. This pioneering venture is designed to expedite market access for drug innovators. The initiative involves a strategic alliance with OECHSLER Health, integrating their manufacturing and assembly proficiency with Merxin’s exclusive SMI design. Their collective objective is to establish elevated industry benchmarks concerning intellectual property safeguards, performance, dependability, speed, and cost-efficiency.
Soft Mist Inhalers Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the soft mist inhalers market are Boehringer Ingelheim Pharma GmbH & Co. KG, AstraZeneca plc, GlaxoSmithKline plc, Novartis International AG, Teva Pharmaceutical Industries Ltd., Viatris Inc., Cipla Limited, Chiesi Farmaceutici S.p.A., Sunovion Pharmaceuticals Inc., Orion Corporation, Lupin Limited, Dr. Reddy’s Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Aurobindo Pharma Limited, Almirall S.A., Sandoz International GmbH, Zydus Lifesciences Limited, Hikma Pharmaceuticals plc, Bial – Portela & Ca. S.A., Menarini Group, Sanofi S.A., Abbott Laboratories, Pfizer Inc., Otsuka Pharmaceutical Co. Ltd., Takeda Pharmaceutical Company Limited
View The Full Soft Mist Inhalers Market Report:
Soft Mist Inhalers Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the soft mist inhalers market in 2025. The regions covered in the soft mist inhalers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model